He SUN,Xijun YAN,Naifeng WU,Kaijing YAN,Yonghong ZHU,Shunnan ZHANG,Xiaolin BAI,XIaohui MA,Yi HE,Ting LI,Lei LI
申请号：
US15560573
公开号：
US20180050015A1
申请日:
2016.03.22
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A pharmaceutical composition is prepared from the following raw materials (in parts by weight): silybin (8.75-60), phospholipid (15-65), a Puer tea extract (25-200), and vitamin E (6.25-40). The composition has the effect of treating non-alcoholic fatty liver diseases.
